OTRADI Board of Directors

Daniel M. Dorsa, Ph.D.
Vice President for Research
Oregon Health and Sciences University

Jonathan Fink, Ph.D.
Vice President for Research and Strategic Partnerships
Portland State University

David Forman
Partner
Tonkon Torp, LLP

Rep. Mitch Greenlick, Ph.D.
State Representative
Oregon State Legislature

Kenton Gregory, M.D.
Medical Director
Oregon Health and Sciences University Center for Regenerative Medicine

Linda Hansen, Ph.D.
Senior Technology Development Associate
University of Oregon

Robert Jordan, Ph.D.
Director of Biology
Gilead Sciences

David Lyon, Ph.D.
Vice President of Research
Bend Research Inc.

Dennis McNannay
Executive Director
Oregon Bioscience Association

Chockalingam Palaniappan, Ph.D.
Vice President of Research and Development
Life Technologies

Richard Spinrad, Ph.D.
Vice President for Research
Oregon State University

Carl Weissman, Ph.D.
President and CEO
Accelerator Corporation

OTRADI Scientific Advisory Board

Bruce Branchaud, Ph.D.
Professor Emeritus
University of Oregon, Department of Chemistry

Adam Carroll
Research Biologist
Bend Research Inc.

Klaus Fruh, Ph.D.
Professor of Microbiology and Immunology
Oregon Health and Sciences University

Michael M. Haley, Ph.D.
Professor of Chemistry and Member of
University of Oregon

Jeff King, Ph.D.
Chief Operating Officer
ID Biopharma Inc.

Taifo Mahmud, Ph.D.
Associate Professor of Pharmaceutical Sciences
Oregon State University

Jay A. Nelson, Ph.D.
Director of Vaccine and Gene Therapy Institute
Oregon Health and Sciences University

Mary Stenzel-Poore, Ph.D.
Professor of Molecular Microbiology and Immunology
Oregon Health and Sciences University

Robert M. Strongin, Ph.D.
Professor of Organic Chemistry
Portland State University